Abbott Seeks FDA approval for cancer drug despite failed trials – WSJ Mon, 12 Sep 2005 Abbott Laboratories is asking the FDA to approve a cancer drug even though it failed in clinical trials to demonstrate a benefit greater than placebo–which is a minimal FDA requirement. The Wall Street Journal…
Testimony by Vera Hassner Sharav, President ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) www.ahrp.org Hearing of the NYS Assembly Committee on Health and Committee on Children and Families September 8, 2005 New York City I speak on behalf of the ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP), the organization that filed the…
Joint Commission on Accreditation of Healthcare Orgs & NCQA Fri, 9 Sep 2005 After much hand wringing following public disclosrure that the current IRB (institutional review board) research review and approval process is so inadequate and unreliable, the (then) outgoing Secretary of Health and Human Services, Donna Shalala, acknowledged in…
New Diabetes Drug Increases Mortality / Morbidity – FDA “approvable” letter Challenged Fri, 21 Oct 2005 Today’s newspaper reports about a lethal new diabetes drug that the FDA was poised to approve makes abundantly clear that The New York Times got it wrong when it gave the FDA high marks…
Russian Roulette Medicine: More kids get multiple psychiatric drugs Wed, 3 Aug 2005 Stop the madness! Child psychiatrist, Joseph Penn, advises: “Parents shouldn’t passively accept whatever doctors recommend for children with behavior or psychiatric problems.” “We just don’t have the efficacy or safety data to back up what is common…
On behalf of the Alliance for Human Research Protection, or AHRP, I want to thank the members of the Committee, for this opportunity to share with you our understanding of the complex problems presented by medical research involving vulnerable populations, such as prisoners and children. We appreciate your difficult job, and recognize that you will need to exercise courage in your assigned mission, which is to protect prisoners from research abuse and exploitation.
“Courage,” in this context, means the courage to acknowledge uncomfortable facts about current practice and to speak truth to power,
AHRP Testimonies and Presentations Sep 8, 2005: AHRP Testimony: NYS Hearing –AIDS Drug /Vaccine Experiments on Foster Children July 18, 2005: Cheaper than Chimpanzees Statement by Vera Hassner Sharav before the Committee on Ethical Consideration for Revisions to DHHS Regulations on Protection of Prisoners Involved in Research July 2-Â 8, 2005:…
Tom Cruise re-ignited the debate about psychiatry–its false claims & drug hazards – Florida Medicaid restricts Fri, 01 Jul 2005 Tom Cruise “kicked off a debate over a subject that a lot of people don’t feel comfortable discussing: whether Americans are too quick to turn to prescription drugs and whether…
Grassley Pushes FDA: Transparency, Accountability & Independence / Whistleblowers are essential Witnesses Wed, 8 Jun 2005 The FDA has once again demonstrated bad faith when it appointed an industry biased panel to monitor drug safety. The Washington Post reports that FDA safety officer Dr. David Graham, who blew the whistle…
60 Minutes: Insider’s Rx for Drug Costs – Peter Rost Hits a Homer! Mon, 6 Jun 2005 Dr. Peter Rost, vice-president of marketing, Pfizer Corp., has blown the lid off the pharmaceutical industry and its misrepresentation of why the American taxpayer is being fleeced by drug companies who charge the…
AMERICA’S OVERMEDICATED CHILDREN By Vera Sharav YOUTH and MEDICINES in June 1-3, 2005 KILEN: Consumers Institute for Medicines and Health SWEDEN “Forgotten Children” is an investigative report by Carole Keeton Strayhorn,[1] the Texas Comptroller (2004) who uncovered evidence that 60% of children in the Texas foster care system are being…
AHRP Speaks Out Dec 12, 2005: Mental Health Screening: A PhRMA Friendly Remedy for Societal Problems. Presentation by Vera Sharav, American Public Health Association Nov 2005: Analysis of S. 1873 – The Biodefense and Pandemic Vaccine and Drug Development Act of 2005 – Karen R. Effrem, MD June 1-3, 2005:…
